Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors

• Alexandra A. Lambert ,

  Contributed equally to this work with: Alexandra A. Lambert, Arezki Azzi

  Affiliation Centre de recherche du CHU de Québec Infectious Diseases and Immunology, Quebec, Canada

  ⨯
• Arezki Azzi ,

  Contributed equally to this work with: Alexandra A. Lambert, Arezki Azzi

  * E-mail: caroline.gilbert@crchul.ulaval.ca (CG); michel.j.tremblay@crchul.ulaval.ca (MJT); arezkiazzi@yahoo.ca (AA)

  Affiliations Endocrinology and Genomics (Faculty of Medicine), Université Laval, Quebec, Canada, Department of pharmacology, College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia

  ⨯
• Sheng-Xiang Lin,

  Affiliation Endocrinology and Genomics (Faculty of Medicine), Université Laval, Quebec, Canada

  ⨯
• Geneviève Allaire,

  Affiliation Centre de recherche du CHU de Québec Infectious Diseases and Immunology, Quebec, Canada

  ⨯
• Karianne P. St-Gelais,

  Affiliation Centre de recherche du CHU de Québec Infectious Diseases and Immunology, Quebec, Canada

  ⨯
• Michel J. Tremblay ,

  * E-mail: caroline.gilbert@crchul.ulaval.ca (CG); michel.j.tremblay@crchul.ulaval.ca (MJT); arezkiazzi@yahoo.ca (AA)

  Affiliation Centre de recherche du CHU de Québec Infectious Diseases and Immunology, Quebec, Canada

  ⨯
• Caroline Gilbert

  * E-mail: caroline.gilbert@crchul.ulaval.ca (CG); michel.j.tremblay@crchul.ulaval.ca (MJT); arezkiazzi@yahoo.ca (AA)

  Affiliation Centre de recherche du CHU de Québec Infectious Diseases and Immunology, Quebec, Canada

  ⨯